Compare DMRA & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | WB |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | 2014 |
| Metric | DMRA | WB |
|---|---|---|
| Price | $20.40 | $6.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 17 |
| Target Price | ★ $46.89 | $8.24 |
| AVG Volume (30 Days) | 607.7K | ★ 883.9K |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 9.44% |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.11 |
| Revenue Next Year | N/A | $0.78 |
| P/E Ratio | ★ N/A | $5.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $6.37 |
| 52 Week High | $34.89 | $12.77 |
| Indicator | DMRA | WB |
|---|---|---|
| Relative Strength Index (RSI) | 31.99 | 32.11 |
| Support Level | $18.99 | N/A |
| Resistance Level | $26.76 | $6.79 |
| Average True Range (ATR) | 1.59 | 0.10 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 15.83 | 25.00 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.